A Prospective, multi-center, randomized controlled trial of the IMPELLA RECOVER LP 2.5 System versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing Non Emergent High Risk PCI [Protect II]

ID Number 08-0386

Principal Investigator(s)
Samin K Sharma

Department(s) or Division(s)

Research Entity
The Zena and Michael A. Wiener Cardiovascular Institute


The purpose of the study is to assess the safety and efficacy of the Impella 2.5 system compared to intra-aortic balloon pump (IABP) use in participants undergoing non-emergent high-risk percutaneous coronary intervention (stent placement). The goal is to monitor the major adverse events like death, stroke and heart attack. The outcome will be compared to the control group treated with IABP.  

Contact Information
Kameswari Vallabhajosyula
(212) 241-5696

Recruiting Patients: Yes